By Steven ReinbergHealthDay Reporter
THURSDAY,March 10, 2016 (HealthDay News) — A two-drug combo quickly shrinks certain breast cancer tumors before surgery or chemotherapy in some women, or British researchers report.
The specific breast cancer is called human epidermal growth factor receptor 2 (HER2) positive. The drug combination — lapatinib (Tykerb) and trastuzumab (Herceptin) — shrank HER2-positive [...]
Source: health.com